SCHEMBL14865487

SCHEMBL14865487

CNC1CCCN2CCCCC(C(C)=O)N2C1=O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACE P12821 3/20 0.41
MME P08473 2/20 0.41
CNR2 P34972 3/20 0.30
CNR1 P21554 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8279385 0.97 ACE (0.42) ACEMMECNR2
SCHEMBL8280285 0.93 ACE (0.43) ACEMME
SCHEMBL8280295 0.93 ACE (0.43) ACEMME
SCHEMBL8280287 0.87 ACE (0.38) ACEMME
SCHEMBL8358947 0.85 ACE (0.53) ACEMME
SCHEMBL8280288 0.85 ACE (0.36) ACEMME
SCHEMBL13815133 0.78 ACE (0.46) ACEMME
SCHEMBL8278667 0.78 ACE (0.33) ACEMME
SCHEMBL13815134 0.76 ACE (0.47) ACEMME
SCHEMBL8279386 0.72 MME (0.30) ACEMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1692157-B1 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE VERTEX PHARMA (US) 2013-04-17 EP disclosed